Axon Enterprise, Inc. (NASDAQ:AXON) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Axon Enterprise, Inc. (NASDAQ:AXON) have received a consensus rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $604.67.

A number of brokerages have recently issued reports on AXON. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Needham & Company LLC reiterated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the sale, the insider now owns 124,243 shares of the company’s stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,792 shares of company stock valued at $1,087,843. Corporate insiders own 5.70% of the company’s stock.

Institutional Investors Weigh In On Axon Enterprise

Several large investors have recently made changes to their positions in AXON. Atria Investments Inc increased its position in shares of Axon Enterprise by 31.4% during the third quarter. Atria Investments Inc now owns 3,901 shares of the biotechnology company’s stock worth $1,559,000 after acquiring an additional 933 shares in the last quarter. Los Angeles Capital Management LLC bought a new stake in shares of Axon Enterprise during the third quarter worth $709,000. Apollon Wealth Management LLC increased its position in shares of Axon Enterprise by 11.3% during the third quarter. Apollon Wealth Management LLC now owns 1,304 shares of the biotechnology company’s stock worth $521,000 after acquiring an additional 132 shares in the last quarter. GSA Capital Partners LLP increased its position in shares of Axon Enterprise by 61.2% during the third quarter. GSA Capital Partners LLP now owns 1,736 shares of the biotechnology company’s stock worth $694,000 after acquiring an additional 659 shares in the last quarter. Finally, KBC Group NV increased its position in shares of Axon Enterprise by 80.6% during the third quarter. KBC Group NV now owns 12,397 shares of the biotechnology company’s stock worth $4,954,000 after acquiring an additional 5,532 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $560.00 on Friday. Axon Enterprise has a 12 month low of $273.52 and a 12 month high of $715.99. The company’s 50-day moving average price is $591.90 and its two-hundred day moving average price is $542.26. The firm has a market cap of $42.91 billion, a PE ratio of 144.70, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.